Non - alcoholic steatohepatitis
Clinical trials for Non - alcoholic steatohepatitis explained in plain language.
Never miss a new study
Get alerted when new Non - alcoholic steatohepatitis trials appear
Sign up with your email to follow new studies for Non - alcoholic steatohepatitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug semaglutide tested as potential treatment for fatty liver disease NASH
Disease control OngoingThis study tests whether semaglutide, a medicine already used for type 2 diabetes, can help people with NASH, a serious liver condition. About 1205 adults with NASH and liver scarring (stage 2 or 3) will receive weekly injections of semaglutide or a placebo for up to 5 years. The…
Matched conditions: NON - ALCOHOLIC STEATOHEPATITIS
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New scanner aims to spot fatty liver without needles
Diagnosis CancelledThis study was designed to test a new thermo-acoustic imaging device that may help diagnose fatty liver disease without invasive procedures. It would have compared the device's accuracy to standard MRI scans in adults aged 18-70 with known or suspected fatty liver. However, the s…
Matched conditions: NON - ALCOHOLIC STEATOHEPATITIS
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
Blood test and AI could spot liver cancer early, saving lives
Knowledge-focused OngoingThis study follows 2,002 people at high risk for liver cancer to find better ways to detect it early. Researchers are testing a panel of blood-based miRNA markers, gut microbiome changes, and MRI-based AI algorithms to predict who develops the disease. The goal is to improve on c…
Matched conditions: NON - ALCOHOLIC STEATOHEPATITIS
Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC